An expert committee today said a suspected serious adverse event following COVID-19 vaccination did not have a direct link with the jab. The Expert Committee on Clinical Events Assessment Following COVID-19 Immunisation made the statement after it convened an urgent meeting to assess the case. The 63-year-old man, who received a dose of the Sinovac COVID-19 vaccine on February 26, suffered from acute shortness of breath with cough and attended Queen Elizabeth Hospital by himself in the early morning of February 28. His condition worsened rapidly and he succumbed that morning. According to the Hospital Authority, the patient was a heavy smoker, had a history of diabetes mellitus, hypertension, hyperlipidemia, obesity and suspected ischemic heart disease. The preliminary autopsy information revealed that he had serious coronary heart disease which led to acute myocardial infarction and pulmonary oedema, resulting in respiratory failure before passing away. Having cons
The Innovation & Technology Commission today said it is inviting applications for the 2021 Innovation & Technology Support Programme until May 21.
The programme provides funding support for platform and seed research and development projects by local public research institutes and R&D centres.
Platform projects are industry-oriented and have potential for commercialisation, while seed projects need to be exploratory and forward-looking.
For enquiries, contact the commission by email or call 3655 5678.
http://dlvr.it/RtCH46
http://dlvr.it/RtCH46